Germ Line Deletion Reveals a Nonessential Role of Atypical Mitogen-Activated Protein Kinase 6/Extracellular Signal-Regulated Kinase 3

REFERENCES

• Cargnello M, Roux PP. 2011. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev 75:50–83. https://doi.org/10.1128/MMBR.00031-10.
   PubMed Web of Science ®Google Scholar
• Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, Morgenbesser SD, DePinho RA, Panayotatos N, Cobb MH, Yancopoulos GD. 1991. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65:663–675.
   PubMed Web of Science ®Google Scholar
• Zhu AX, Zhao Y, Moller DE, Flier JS. 1994. Cloning and characterization of p97MAPK, a novel human homolog of rat ERK-3. Mol Cell Biol 14:8202–8211.
   PubMed Web of Science ®Google Scholar
• Gonzalez FA, Raden DL, Rigby MR, Davis RJ. 1992. Heterogeneous expression of four MAP kinase isoforms in human tissues. FEBS Lett 304:170–178.
   PubMed Web of Science ®Google Scholar
• Déléris P, Trost M, Topisirovic I, Tanguay P-L, Borden KLB, Thibault P, Meloche S. 2011. Activation loop phosphorylation of ERK3/ERK4 by group I p21-activated kinases (PAKs) defines a novel PAK-ERK3/4-MAPK-activated protein kinase 5 signaling pathway. J Biol Chem 286:6470–6478. https://doi.org/10.1074/jbc.M110.181529.
   PubMedGoogle Scholar
• la Mota-Peynado De A, Chernoff J, Beeser A. 2011. Identification of the atypical MAPK Erk3 as a novel substrate for p21-activated kinase (Pak) activity. J Biol Chem 286:13603–13611. https://doi.org/10.1074/jbc.M110.181743.
   PubMed Web of Science ®Google Scholar
• Seternes O-M, Mikalsen T, Johansen B, Michaelsen E, Armstrong CG, Morrice NA, Turgeon B, Meloche S, Moens U, Keyse SM. 2004. Activation of MK5/PRAK by the atypical MAP kinase ERK3 defines a novel signal transduction pathway. EMBO J 23:4780–4791. https://doi.org/10.1038/sj.emboj.7600489.
   PubMed Web of Science ®Google Scholar
• Perander M, Aberg E, Johansen B, Dreyer B, Guldvik IJ, Outzen H, Keyse SM, Seternes O-M. 2008. The Ser(186) phospho-acceptor site within ERK4 is essential for its ability to interact with and activate PRAK/MK5. Biochem J 411:613–622. https://doi.org/10.1042/BJ20071369.
   PubMed Web of Science ®Google Scholar
• Kant S, Schumacher S, Singh MK, Kispert A, Kotlyarov A, Gaestel M. 2006. Characterization of the atypical MAPK ERK4 and its activation of the MAPK-activated protein kinase MK5. J Biol Chem 281:35511–35519. https://doi.org/10.1074/jbc.M606693200.
   PubMed Web of Science ®Google Scholar
• Schumacher S, Laass K, Kant S, Shi Y, Visel A, Gruber AD, Kotlyarov A, Gaestel M. 2004. Scaffolding by ERK3 regulates MK5 in development. EMBO J 23:4770–4779. https://doi.org/10.1038/sj.emboj.7600467.
   PubMed Web of Science ®Google Scholar
• Brand F, Schumacher S, Kant S, Menon MB, Simon R, Turgeon B, Britsch S, Meloche S, Gaestel M, Kotlyarov A. 2012. The extracellular signal-regulated kinase 3 (mitogen-activated protein kinase 6 [MAPK6])-MAPK-activated protein kinase 5 signaling complex regulates septin function and dendrite morphology. Mol Cell Biol 32:2467–2478. https://doi.org/10.1128/MCB.06633-11.
   PubMed Web of Science ®Google Scholar
• Hansen CA, Bartek J, Jensen S. 2008. A functional link between the human cell cycle-regulatory phosphatase Cdc14A and the atypical mitogen-activated kinase Erk3. Cell Cycle 7:325–334. https://doi.org/10.4161/cc.7.3.5354.
   PubMed Web of Science ®Google Scholar
• Li S, Ou X-H, Wang Z-B, Xiong B, Tong J-S, Wei L, Li M, Yuan J, Ouyang Y-C, Hou Y, Schatten H, Sun Q-Y. 2010. ERK3 is required for metaphase-anaphase transition in mouse oocyte meiosis. PLoS One 5:e13074–e13078. https://doi.org/10.1371/journal.pone.0013074.
   PubMed Web of Science ®Google Scholar
• Long W, Foulds CE, Qin J, Liu J, Ding C, Lonard DM, Solis LM, Wistuba II, Tsai SY, Tsai M-J, O'Malley BW. 2012. ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion. J Clin Investig 122:1869–1880. https://doi.org/10.1172/JCI61492.
   PubMed Web of Science ®Google Scholar
• Wang W, Bian K, Vallabhaneni S, Zhang B, Wu R-C, O'Malley BW, Long W. 2014. ERK3 promotes endothelial cell functions by upregulating SRC-3/SP1-mediated VEGFR2 expression. J Cell Physiol 229:1529–1537. https://doi.org/10.1002/jcp.24596.
   PubMed Web of Science ®Google Scholar
• Bian K, Muppani NR, Elkhadragy L, Wang W, Zhang C, Chen T, Jung S, Seternes O-M, Long W. 2016. ERK3 regulates TDP2-mediated DNA damage response and chemoresistance in lung cancer cells. Oncotarget 7:6665–6675. https://doi.org/10.18632/oncotarget.6682.
   PubMedGoogle Scholar
• Klinger S, Turgeon B, Lévesque K, Wood GA, Aagaard-Tillery KM, Meloche S. 2009. Loss of Erk3 function in mice leads to intrauterine growth restriction, pulmonary immaturity, and neonatal lethality. Proc Natl Acad Sci U S A 106:16710–16715. https://doi.org/10.1073/pnas.0900919106.
   PubMed Web of Science ®Google Scholar
• Rousseau J, Klinger S, Rachalski A, Turgeon B, Déléris P, Vigneault E, Poirier-Héon J-F, Davoli MA, Mechawar N, Mestikawy El S, Cermakian N, Meloche S. 2010. Targeted inactivation of Mapk4 in mice reveals specific nonredundant functions of Erk3/Erk4 subfamily mitogen-activated protein kinases. Mol Cell Biol 30:5752–5763. https://doi.org/10.1128/MCB.01147-10.
   PubMed Web of Science ®Google Scholar
• Marquis M, Daudelin JF, Boulet S, Sirois J, Crain K, Mathien S, Turgeon B, Rousseau J, Meloche S, Labrecque N. 2014. The catalytic activity of the mitogen-activated protein kinase extracellular signal-regulated kinase 3 is required to sustain CD4+ CD8+ thymocyte survival. Mol Cell Biol 34:3374–3387. https://doi.org/10.1128/MCB.01701-13.
   PubMed Web of Science ®Google Scholar
• Marquis M, Boulet S, Mathien S, Rousseau J, Thébault P, Daudelin J-F, Rooney J, Turgeon B, Beauchamp C, Meloche S, Labrecque N. 2014. The non-classical MAP kinase ERK3 controls T cell activation. PLoS One 9:e86681. https://doi.org/10.1371/journal.pone.0086681.
   Google Scholar
• Sirois J, Daudelin J-F, Boulet S, Marquis M, Meloche S, Labrecque N. 2015. The atypical MAPK ERK3 controls positive selection of thymocytes. Immunology 145:161–169. https://doi.org/10.1111/imm.12433.
   PubMed Web of Science ®Google Scholar
• Turgeon B, Lang BF, Meloche S. 2002. The protein kinase ERK3 is encoded by a single functional gene: genomic analysis of the ERK3 gene family. Genomics 80:673–680.
   PubMed Web of Science ®Google Scholar
• Wu Y, Wang C, Sun H, LeRoith D, Yakar S. 2009. High-efficient FLPo deleter mice in C57BL/6J background. PLoS One 4:e8054. https://doi.org/10.1371/journal.pone.0008054.
   Google Scholar
• Lewandoski M, Wassarman KM, Martin GR. 1997. Zp3-cre, a transgenic mouse line for the activation or inactivation of loxP-flanked target genes specifically in the female germ line. Curr Biol 7:148–151.
   PubMed Web of Science ®Google Scholar
• Saini M, Sinclair C, Marshall D, Tolaini M, Sakaguchi S, Seddon B. 2010. Regulation of Zap70 expression during thymocyte development enables temporal separation of CD4 and CD8 repertoire selection at different signaling thresholds. Sci Signal 3:ra23–ra23. https://doi.org/10.1126/scisignal.2000702.
   PubMed Web of Science ®Google Scholar
• West DB, Engelhard EK, Adkisson M, Nava AJ, Kirov JV, Cipollone A, Willis B, Rapp J, de Jong PJ, Lloyd KC. 2016. Transcriptome analysis of targeted mouse mutations reveals the topography of local changes in gene expression. PLoS Genet 12:e1005691-19. https://doi.org/10.1371/journal.pgen.1005691.
   Google Scholar
• Kaul A, Köster M, Neuhaus H, Braun T. 2000. Myf-5 revisited: loss of early myotome formation does not lead to a rib phenotype in homozygous Myf-5 mutant mice. Cell 102:17–19.
   PubMed Web of Science ®Google Scholar
• Braun T, Rudnicki MA, Arnold HH, Jaenisch R. 1992. Targeted inactivation of the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal death. Cell 71:369–382.
   PubMed Web of Science ®Google Scholar
• Wang B, Wang N, Whitehurst CE, She J, Chen J, Terhorst C. 1999. T lymphocyte development in the absence of CD3 epsilon or CD3 gamma delta epsilon zeta. J Immunol 162:88–94.
   PubMed Web of Science ®Google Scholar
• Aberg E, Perander M, Johansen B, Julien C, Meloche S, Keyse SM, Seternes O-M. 2006. Regulation of MAPK-activated protein kinase 5 activity and subcellular localization by the atypical MAPK ERK4/MAPK4. J Biol Chem 281:35499–35510. https://doi.org/10.1074/jbc.M606225200.
   PubMed Web of Science ®Google Scholar
• Shi Y, Kotlyarov A, Laabeta K, Gruber AD, Butt E, Marcus K, Meyer HE, Friedrich A, Volk H-D, Gaestel M. 2003. Elimination of protein kinase MK5/PRAK activity by targeted homologous recombination. Mol Cell Biol 23:7732–7741.
   PubMed Web of Science ®Google Scholar
• Ronkina N, Johansen C, Bohlmann L, Lafera J, Menon MB, Tiedje C, Laaß K, Turk BE, Iversen L, Kotlyarov A, Gaestel M. 2015. Comparative analysis of two gene-targeting approaches challenges the tumor-suppressive role of the protein kinase MK5/PRAK. PLoS One 10:e0136138. https://doi.org/10.1371/journal.pone.0136138.
   Google Scholar
• Aberg E, Torgersen KM, Johansen B, Keyse SM, Perander M, Seternes O-M. 2009. Docking of PRAK/MK5 to the atypical MAPKs ERK3 and ERK4 defines a novel MAPK interaction motif. J Biol Chem 284:19392–19401. https://doi.org/10.1074/jbc.M109.023283.
   PubMed Web of Science ®Google Scholar
• Déléris P, Rousseau J, Coulombe P, Rodier G, Tanguay P-L, Meloche S. 2008. Activation loop phosphorylation of the atypical MAP kinases ERK3 and ERK4 is required for binding, activation and cytoplasmic relocalization of MK5. J Cell Physiol 217:778–788. https://doi.org/10.1002/jcp.21560.
   PubMed Web of Science ®Google Scholar